CBD oil in MCT (5%)

Natural THC-free broad-spectrum cannabidiol produced in Switzerland

This CBD oil in MCT oil is a gentle formulation with 5% broad-spectrum cannabidiol (500 mg CBD) obtained from Swiss certified hemp. The product is completely THC-free and is combined with MCT oil, which is an easily absorbed carrier oil for gentle and natural skin care. Each bottle comes with a medical pipette for easy and accurate dosing.

Benefits and effects

CBD oil in MCT provides the skin with essential fatty acids that are absorbed quickly and help keep the skin balanced and moist. MCT oil, known for its medium-chain triglycerides, supplies the skin with valuable fatty acids and supports the skin's natural barrier. CBD can also have a calming and soothing effect that is well suited for dry and sensitive skin. Note: This product is intended for cosmetic use only and is not intended for ingestion.

Ingredients and contents

• Ingredients: MCT oil, broad-spectrum CBD oil (500 mg cannabidiol from Swiss hemp)
• Contents per bottle: 10 ml, corresponding to approx. 270 drops
• THC content: 0.0% - lab tested and confirmed THC free

Instructions for use

Shake the bottle well before use. Apply a few drops to the desired skin area morning and evening for optimal effect. For people who have not used CBD products before, it is recommended to start with a low dose. Store in a cool, dry place, out of direct sunlight, to preserve product quality.

Quality control and test results

Our CBD products undergo extensive quality checks. This CBD oil has been tested in Swiss laboratories for cannabinoid content, microbiological safety and the absence of heavy metals, pesticides and other pollutants. We work with a British partner who supplies biodegradable packaging, which supports our environmentally friendly production practices and provides a sustainable production chain.

Reservation

Only for adults over 18 years of age. Not recommended for pregnant or lactating women without medical approval. This product is intended for cosmetic use and is not intended for oral administration. Uno Vita AS makes no medical claims about the product's effectiveness. We always recommend consulting a healthcare professional before use if you have medical conditions or are taking prescription medications.

Freedom of expression and right to information

Uno Vita reserves the right to share publicly available research and information on health and wellness technologies, natural substances, vitamins and the like, in accordance with laws on freedom of expression. This includes:

• United Nations Universal Declaration of Human Rights (1948): Article 19
• The International Covenant on Civil and Political Rights (1966): Article 19
• Section 100 of the Norwegian Constitution
• America's First Amendment

Relevant references:

1. Huestis, M.A. (2007). Human Cannabinoid Pharmacokinetics.
2. Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids.
3. Mechoulam, R., & Parker, L.A. (2013). The endocannabinoid system and the brain.
4. Russo, E. B. (2011). Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
5. Pertwee, R.G. (2006). Cannabinoid pharmacology.
6. Pisanti, S., et al. (2017). Cannabidiol: State of the art and new challenges for therapeutic applications.
7. McPartland, J.M., et al. (2015). Cannabidiol modulation of the endocannabinoid system.
8. Zuardi, A.W. (2008). Cannabidiol: A drug with a wide spectrum of action.
9. Pamplona, ​​F.A., et al. (2018). The anti-inflammatory properties of cannabidiol.
10. Shannon, S., et al. (2019). Cannabidiol in anxiety and sleep.
11. Ashton, C.H. (2001). Effects of cannabis: A brief review.
12. Pertwee, R.G., et al. (2018). Cannabinoids in health and disease.